About IriSys
IriSys is a company based in San Diego (United States) founded in 1996 was acquired by Recro in August 2021. IriSys has raised $6.3 million across 1 funding round from investors including Bend Bioscience. The company has 59 employees. IriSys operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter San Diego, United States
- Employees 59
- SectorsHealthcare
- Website irisys.com
- Social LinkedIn
- Acquired by Recro (Aug 2021)
- Legal Name Irisys, Llc
- Total Equity Funding$6.3M (USD)
in 1 rounds
- Latest Funding Round$6.3M (USD), Series A
Feb 2015
- Investors
- Employee Count59
- Acquired byRecro
(Aug 2021)
Funding Insights of IriSys
IriSys has successfully raised a total of $6.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.3 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.3M
- Total Rounds 1
- Last Round Series A — $6.3M
- First Round $6.3M
(Feb 2015)
All 1 funding rounds of IriSys with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2015 | $6.3M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in IriSys
IriSys has secured backing from 1 investor. Prominent investors backing the company include Bend Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bend Bioscience is engaged in pharmaceutical development and manufacturing. | – | recrocdmo.com | Bend, United States |
Investor details for IriSys
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IriSys
3 dated milestones of IriSys across 25 years, from founding to its latest funding, stage changes and deals.
- Founded IriSys is founded.
- Funding First funding round of $6.3M.
- Exit Acquired by Recro.
Competitors of IriSys
IriSys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| almacgroup.com | 2001 | Craigavon, United Kingdom | $338.8M | 2,109 | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| indoco.com | 1947 | Mumbai, India | – | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | |
| concordbiotech.com | 2000 | Ahmedabad, India | – | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | |
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. | |
| aurobindo.com | 1986 | Hyderabad, India | – | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| asymchem.com | 1995 | Morrisville, United States | – | 48 | APIs and peptides are developed and manufactured by Asymchem. | |
| seqens.com | 2003 | Ecully, France | – | 44 | Contract manufacturing services for small molecules and peptides are provided. | |
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| biophore.com | 2007 | Hyderabad, India | $2.74M | 639 | Niche generic pharmaceuticals are developed and manufactured for industry needs. | |
| pharm-int.com | 1994 | Hunt Valley, United States | $171.23M | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. |
Detailed competitors of IriSys
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IriSys
Websites that share an audience with IriSys (irisys.com).
Websites whose visitors overlap most with IriSys. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| corerxpharma.com | 100% | – | – | View details | |
| velescopharma.com | 100% | – | – | View details | |
| pharmatek.com | 100% | – | – | View details | |
| dptlabs.com | 100% | 1.5K | #8,022,749 | View details | |
| aprecia.com | 99% | 2.6K | #5,861,353 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for IriSys
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Irisys
Complete news archive for IriSys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to IriSys
10 companies that operate in the same segment as IriSys (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IriSys
IriSys was founded in 1996 and raised its 1st funding round 19 years after it was founded.
IriSys is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
IriSys is a funded company, having raised a total of $6.3M across 1 funding round to date. The company's 1st funding round was a Series A of $6.3M, raised on Feb 2015.
IriSys has 59 employees.
Founded in 1996, IriSys operates as a contract development and manufacturing organization in the pharmaceutical sector, based in San Diego, United States. Formulation development, cGMP manufacturing for clinical trial materials and commercial products, and consulting on drug development processes are provided. Over 100 drug products have been advanced from discovery through Phase III to commercialization. Services encompass oral, topical, and injectable dosage forms, including microspheres and lyophilized variants.
IriSys's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
IriSys has 1 investor. Key investors include Bend Bioscience.
IriSys operates through Irisys, Llc.
Yes. IriSys was acquired by Recro in August 2021.